BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37909728)

  • 1. Hypoxia and HIF-1α promote lytic
    Lee S-C; Naik NG; Tombácz D; Gulyás G; Kakuk B; Boldogkői Z; Hall K; Papp B; Boulant S; Toth Z
    J Virol; 2023 Nov; 97(11):e0097223. PubMed ID: 37909728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.
    Haque M; Kousoulas KG
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors.
    Veeranna RP; Haque M; Davis DA; Yang M; Yarchoan R
    J Virol; 2012 Jan; 86(2):1097-108. PubMed ID: 22090111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
    Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
    J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.
    Toth Z; Brulois K; Lee HR; Izumiya Y; Tepper C; Kung HJ; Jung JU
    PLoS Pathog; 2013; 9(12):e1003813. PubMed ID: 24367262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRC1-independent binding and activity of RYBP on the KSHV genome during de novo infection.
    Lee SC; Toth Z
    PLoS Pathog; 2022 Aug; 18(8):e1010801. PubMed ID: 36026503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma.
    Shrestha P; Davis DA; Veeranna RP; Carey RF; Viollet C; Yarchoan R
    PLoS Pathog; 2017 Sep; 13(9):e1006628. PubMed ID: 28922425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.
    Kong X; Li D; Mansouri A; Kang G; Sayood K; West J; Wood C
    J Virol; 2021 Jun; 95(13):e0000321. PubMed ID: 33853962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
    Li D; Mosbruger T; Verma D; Swaminathan S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.